CN Stock MarketDetailed Quotes

002589 Realcan Pharmaceutical Group

Watchlist
  • 2.77
  • -0.11-3.82%
Market Closed Jan 3 15:00 CST
4.17BMarket Cap102.59P/E (TTM)

Realcan Pharmaceutical Group Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-15.19%4.69B
-34.60%4.04B
-41.63%4.02B
-5.23%5.06B
-3.59%5.53B
14.92%6.18B
38.07%6.89B
16.63%5.34B
7.89%5.73B
6.86%5.38B
Transactional financial assets
----
----
----
----
600.00%70M
--120M
--100M
----
9.89%10M
----
Notes receivable and accounts receivable
8.15%4.51B
7.62%4.51B
-3.60%4.17B
-7.75%3.98B
-50.09%4.17B
-58.06%4.19B
-63.34%4.33B
-60.81%4.31B
-33.20%8.35B
-23.00%10B
-Notes receivable
103.75%531.01M
167.67%600.58M
1.89%223.15M
7.36%217.04M
-39.60%260.62M
-60.04%224.37M
-84.96%219.02M
-72.03%202.16M
-49.59%431.46M
-35.42%561.56M
-Accounts receivable
1.78%3.98B
-1.43%3.91B
-3.90%3.95B
-8.50%3.76B
-50.66%3.91B
-57.95%3.97B
-60.29%4.11B
-60.02%4.11B
-32.00%7.92B
-22.11%9.44B
Other receivables (including interest and dividends)
-10.97%1.02B
-24.95%927.41M
-29.02%968.76M
-40.73%990.01M
-40.88%1.14B
-36.68%1.24B
-27.20%1.36B
-11.93%1.67B
-0.32%1.93B
-9.36%1.95B
-Other receivable
----
-24.95%927.41M
----
----
----
-36.68%1.24B
----
-11.93%1.67B
----
-9.35%1.95B
Advance payment
115.91%225.52M
46.04%201.04M
-5.84%156.33M
-49.18%97.37M
-77.63%104.45M
-79.31%137.66M
-78.78%166.03M
-70.11%191.59M
-30.11%466.85M
-11.20%665.48M
Inventories
13.19%892.32M
5.68%926.48M
27.17%978.04M
17.24%1.12B
-43.88%788.33M
-48.77%876.69M
-59.21%769.07M
-53.84%954.51M
-35.42%1.4B
-28.94%1.71B
Receivable financing
-35.37%191.04M
-58.38%151.63M
-51.39%130.83M
-16.24%242.01M
3.33%295.58M
39.11%364.3M
17.16%269.15M
7.88%288.92M
23.40%286.04M
22.12%261.89M
Other current assets
-6.95%46.39M
-34.08%46.76M
-5.06%53.46M
-16.13%49.81M
-9.61%49.86M
11.07%70.93M
-60.08%56.31M
-59.08%59.39M
-59.24%55.16M
-52.08%63.86M
Total current assets
-4.76%11.57B
-17.99%10.81B
-24.83%10.48B
-9.99%11.54B
-33.61%12.14B
-34.42%13.18B
-35.97%13.95B
-37.99%12.82B
-20.89%18.29B
-15.62%20.09B
Non Current assets
Other equity investment
0.00%5.22M
-65.71%5.22M
-65.71%5.22M
-65.71%5.22M
-65.71%5.22M
0.00%15.22M
0.00%15.22M
0.00%15.22M
188.89%15.22M
188.89%15.22M
Other non-current financial assets
33.96%191.42M
33.96%191.42M
33.96%191.42M
33.96%191.42M
20.49%142.9M
19.88%142.9M
6.05%142.9M
-5.89%142.9M
-17.12%118.6M
-16.70%119.2M
Investment real estate
-1.95%598.31M
-5.22%595.61M
-1.27%600.44M
-3.22%605.26M
3.06%610.22M
2.05%628.38M
-4.96%608.14M
-2.93%625.42M
22.70%592.08M
52.66%615.78M
Long-term equity investment
-25.50%532.03M
22.57%534.36M
54.10%671.81M
50.34%655.39M
1.11%714.13M
-43.53%435.95M
-41.17%435.95M
-31.75%435.95M
-27.67%706.29M
-20.53%772.03M
Fixed assets
----
-1.52%1.96B
----
----
----
11.31%1.99B
----
2.78%1.98B
----
-15.87%1.78B
Constru in process
----
-15.03%279.68M
----
----
----
-49.46%329.13M
----
-42.62%315.37M
----
16.93%651.23M
Productive biological assets
----
----
--0
----
----
----
----
----
----
0.00%713.39K
Oil and gas assets
----
----
--0
----
----
----
----
----
----
----
Intangible assets
-15.42%492.61M
-12.76%516.58M
-14.41%531.29M
-11.51%552.39M
16.81%582.44M
19.42%592.17M
31.11%620.72M
30.49%624.21M
46.84%498.63M
45.61%495.87M
Development expenditure
----
----
----
----
----
----
----
--0
0.00%9.58M
0.00%9.58M
Goodwill
-0.01%146.67M
-0.01%146.67M
-0.01%146.67M
-0.01%146.67M
-71.55%146.69M
-75.19%146.69M
-76.35%146.69M
-76.35%146.69M
-26.71%515.65M
-16.24%591.18M
Long deferred expense
-41.64%41.44M
-41.56%45.98M
-43.89%50.03M
-32.32%60.87M
-38.75%71.01M
-28.73%78.68M
-32.62%89.16M
-28.06%89.93M
-13.28%115.94M
-18.09%110.4M
Deferred tax assets
190.26%287.25M
249.89%283.71M
137.80%243.38M
166.64%284.44M
-16.61%98.97M
-32.77%81.08M
-13.63%102.35M
-13.17%106.68M
-0.37%118.68M
5.06%120.6M
Usufruct assets
91.78%5.28M
59.33%5.73M
37.02%6.54M
-60.95%2.52M
-91.23%2.75M
-92.09%3.6M
-89.68%4.77M
-88.28%6.45M
-41.92%31.36M
-24.28%45.52M
Other non current assets
-45.55%345.07M
-46.16%357.43M
-54.61%385.44M
-61.97%391.13M
76.29%633.79M
84.82%663.93M
111.00%849.17M
163.13%1.03B
276.74%359.52M
264.05%359.23M
Total non current assets
-8.16%4.85B
-3.63%4.92B
-3.20%5.07B
-6.21%5.17B
-3.90%5.28B
-10.31%5.1B
-8.70%5.24B
-3.71%5.51B
-4.29%5.5B
0.44%5.69B
Total assets
-5.79%16.42B
-13.98%15.73B
-18.92%15.56B
-8.85%16.71B
-26.74%17.43B
-29.10%18.28B
-30.28%19.19B
-30.55%18.33B
-17.58%23.79B
-12.54%25.78B
Liabilities
Current liabilities
Short term loan
76.16%6.51B
30.48%5.53B
-12.40%4.8B
70.74%6.56B
-32.50%3.7B
-25.32%4.24B
11.69%5.48B
-7.81%3.84B
-20.93%5.48B
-28.10%5.68B
Notes payable and accounts payable
-53.88%3.26B
-49.55%3.68B
-39.30%4.23B
-51.75%3.72B
-8.84%7.06B
-11.87%7.29B
-28.35%6.98B
-21.21%7.71B
1.48%7.74B
16.07%8.27B
-Notes payable
-84.88%733.84M
-79.35%1.02B
-67.37%1.51B
-91.30%448.6M
6.68%4.85B
-2.63%4.93B
-25.66%4.62B
-19.86%5.16B
13.40%4.55B
57.38%5.06B
-Accounts payable
14.26%2.52B
12.64%2.66B
15.68%2.73B
28.02%3.27B
-30.93%2.21B
-26.43%2.36B
-33.09%2.36B
-23.78%2.56B
-11.72%3.2B
-17.91%3.21B
Contract liabilities
-11.71%24.95M
-13.81%27.31M
-57.76%17.54M
-8.45%29.12M
-74.09%28.26M
-72.97%31.68M
-64.73%41.53M
-81.80%31.8M
-32.61%109.07M
-27.20%117.21M
Advance receipts
----
----
--0
----
----
----
----
--627.17K
----
----
Salaries payable
9.04%18.69M
-1.08%18.1M
-17.47%17.87M
-20.92%17.91M
-49.18%17.14M
-53.01%18.3M
-40.15%21.65M
-59.41%22.65M
-17.10%33.73M
-6.19%38.94M
Taxs payable
44.35%24.74M
13.71%19.77M
-64.05%16.17M
-48.55%14.78M
-84.45%17.14M
-86.76%17.39M
-76.10%44.99M
-84.97%28.73M
-42.38%110.21M
-32.90%131.39M
Other payable (including interest and dividends)
-54.88%273.4M
-56.47%278.42M
-46.71%368.69M
-56.68%316.91M
-57.26%606M
-58.31%639.65M
-57.20%691.81M
-58.55%731.62M
-35.85%1.42B
-34.38%1.53B
-Interest payable
----
----
----
----
----
----
----
--0
----
----
-Dividend payable
-82.15%3.94M
-89.37%3.94M
-94.12%3.94M
-94.12%3.94M
-93.97%22.09M
-90.64%37.09M
-87.12%67.09M
-87.12%67.09M
260.96%366.6M
514.09%396.34M
-Other payable
----
-54.45%274.47M
----
----
----
-47.05%602.56M
----
-46.60%664.53M
----
-49.95%1.14B
Non current liabilities due within one year
-71.89%2.95M
-72.45%3.05M
694.15%8.99M
-26.50%6.12M
190.81%10.51M
132.55%11.08M
-81.75%1.13M
-49.17%8.33M
-42.66%3.61M
-26.70%4.76M
Other current liabilities
-47.12%42.08M
10.19%99.71M
60.97%115.73M
8.32%97.59M
-56.67%79.57M
-61.52%90.49M
-93.30%71.89M
-69.72%90.09M
-85.77%183.65M
-82.45%235.16M
Total current liabilities
-11.80%10.16B
-21.73%9.65B
-28.13%9.58B
-13.69%10.76B
-23.66%11.52B
-22.96%12.33B
-24.79%13.33B
-24.47%12.47B
-18.59%15.09B
-16.62%16.01B
Current liabilities
Long term loan
184.89%502.26M
177.94%326.85M
982.33%269.5M
288.80%261.27M
129.86%176.3M
64.48%117.6M
-65.89%24.9M
38.56%67.2M
53.40%76.7M
--71.5M
Deferred tax liabilities
26.05%45.1M
25.29%46.16M
19.18%45.79M
17.01%47.48M
26.77%35.78M
24.84%36.84M
-54.02%38.42M
-51.44%40.58M
-81.05%28.23M
-80.19%29.51M
Long term deferred income
177.25%4.84M
-11.73%1.55M
-15.09%1.59M
-16.28%1.62M
-26.99%1.75M
-89.91%1.76M
-89.31%1.87M
-88.95%1.93M
-88.03%2.39M
-13.22%17.41M
Lease liabilities
302.48%4.27M
264.66%4.54M
53.37%4.64M
-69.39%835.71K
-95.93%1.06M
-96.50%1.25M
-92.04%3.03M
-93.03%2.73M
-50.63%26.09M
-40.75%35.62M
Other non current liabilities
----
----
----
----
----
----
----
----
--12.71M
--7.41M
Total non current liabilities
158.96%556.48M
140.79%379.11M
371.32%321.52M
176.77%311.21M
47.07%214.89M
-2.48%157.45M
-68.90%68.22M
-42.64%112.44M
-46.24%146.12M
-30.18%161.46M
Total liabilities
-8.68%10.71B
-19.68%10.03B
-26.09%9.9B
-11.99%11.07B
-22.98%11.73B
-22.75%12.49B
-25.33%13.4B
-24.68%12.58B
-18.99%15.23B
-16.79%16.17B
Shareholders equity
Paid-in capital
0.00%1.5B
0.00%1.5B
0.00%1.5B
0.00%1.5B
0.00%1.5B
0.00%1.5B
0.00%1.5B
0.00%1.5B
0.00%1.5B
0.00%1.5B
Capital reserve funds
1.69%3.59B
1.86%3.59B
0.30%3.72B
0.52%3.72B
4.82%3.53B
-7.95%3.52B
-2.42%3.71B
-7.83%3.7B
-16.31%3.36B
-4.85%3.82B
Surplus reserve funds
4.42%159.53M
4.42%159.53M
4.42%159.53M
4.42%159.53M
0.00%152.77M
0.00%152.77M
0.00%152.77M
0.00%152.77M
13.41%152.77M
13.41%152.77M
Retained profit
4.67%313.54M
-1.69%305.76M
2.64%309.47M
5.15%294.3M
-86.21%299.57M
-85.76%311.01M
-86.09%301.51M
-86.83%279.89M
1.55%2.17B
2.55%2.18B
Less:Treasury stock
--57.65M
--57.65M
0.00%230.65M
0.00%230.65M
----
----
0.00%230.65M
0.00%230.65M
0.00%230.65M
0.00%230.65M
Shareholders equity without minority interests
0.41%5.51B
0.17%5.5B
0.48%5.46B
0.75%5.45B
-21.26%5.48B
-26.18%5.49B
-26.48%5.44B
-28.54%5.41B
-7.98%6.96B
-1.62%7.44B
Minority interests
-6.33%199.14M
-35.33%195.23M
-45.42%192.59M
-45.00%189.18M
-86.66%212.6M
-86.14%301.9M
-83.83%352.84M
-83.82%344M
-36.13%1.59B
-12.52%2.18B
Total shareholder equity
0.16%5.71B
-1.68%5.69B
-2.32%5.66B
-1.99%5.64B
-33.44%5.7B
-39.77%5.79B
-39.55%5.79B
-40.67%5.75B
-14.96%8.56B
-4.32%9.61B
Total liabilityies and equity
-5.79%16.42B
-13.98%15.73B
-18.92%15.56B
-8.85%16.71B
-26.74%17.43B
-29.10%18.28B
-30.28%19.19B
-30.55%18.33B
-17.58%23.79B
-12.54%25.78B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
--
Tianyuanquan Certified Public Accountants Firm (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -15.19%4.69B-34.60%4.04B-41.63%4.02B-5.23%5.06B-3.59%5.53B14.92%6.18B38.07%6.89B16.63%5.34B7.89%5.73B6.86%5.38B
Transactional financial assets ----------------600.00%70M--120M--100M----9.89%10M----
Notes receivable and accounts receivable 8.15%4.51B7.62%4.51B-3.60%4.17B-7.75%3.98B-50.09%4.17B-58.06%4.19B-63.34%4.33B-60.81%4.31B-33.20%8.35B-23.00%10B
-Notes receivable 103.75%531.01M167.67%600.58M1.89%223.15M7.36%217.04M-39.60%260.62M-60.04%224.37M-84.96%219.02M-72.03%202.16M-49.59%431.46M-35.42%561.56M
-Accounts receivable 1.78%3.98B-1.43%3.91B-3.90%3.95B-8.50%3.76B-50.66%3.91B-57.95%3.97B-60.29%4.11B-60.02%4.11B-32.00%7.92B-22.11%9.44B
Other receivables (including interest and dividends) -10.97%1.02B-24.95%927.41M-29.02%968.76M-40.73%990.01M-40.88%1.14B-36.68%1.24B-27.20%1.36B-11.93%1.67B-0.32%1.93B-9.36%1.95B
-Other receivable -----24.95%927.41M-------------36.68%1.24B-----11.93%1.67B-----9.35%1.95B
Advance payment 115.91%225.52M46.04%201.04M-5.84%156.33M-49.18%97.37M-77.63%104.45M-79.31%137.66M-78.78%166.03M-70.11%191.59M-30.11%466.85M-11.20%665.48M
Inventories 13.19%892.32M5.68%926.48M27.17%978.04M17.24%1.12B-43.88%788.33M-48.77%876.69M-59.21%769.07M-53.84%954.51M-35.42%1.4B-28.94%1.71B
Receivable financing -35.37%191.04M-58.38%151.63M-51.39%130.83M-16.24%242.01M3.33%295.58M39.11%364.3M17.16%269.15M7.88%288.92M23.40%286.04M22.12%261.89M
Other current assets -6.95%46.39M-34.08%46.76M-5.06%53.46M-16.13%49.81M-9.61%49.86M11.07%70.93M-60.08%56.31M-59.08%59.39M-59.24%55.16M-52.08%63.86M
Total current assets -4.76%11.57B-17.99%10.81B-24.83%10.48B-9.99%11.54B-33.61%12.14B-34.42%13.18B-35.97%13.95B-37.99%12.82B-20.89%18.29B-15.62%20.09B
Non Current assets
Other equity investment 0.00%5.22M-65.71%5.22M-65.71%5.22M-65.71%5.22M-65.71%5.22M0.00%15.22M0.00%15.22M0.00%15.22M188.89%15.22M188.89%15.22M
Other non-current financial assets 33.96%191.42M33.96%191.42M33.96%191.42M33.96%191.42M20.49%142.9M19.88%142.9M6.05%142.9M-5.89%142.9M-17.12%118.6M-16.70%119.2M
Investment real estate -1.95%598.31M-5.22%595.61M-1.27%600.44M-3.22%605.26M3.06%610.22M2.05%628.38M-4.96%608.14M-2.93%625.42M22.70%592.08M52.66%615.78M
Long-term equity investment -25.50%532.03M22.57%534.36M54.10%671.81M50.34%655.39M1.11%714.13M-43.53%435.95M-41.17%435.95M-31.75%435.95M-27.67%706.29M-20.53%772.03M
Fixed assets -----1.52%1.96B------------11.31%1.99B----2.78%1.98B-----15.87%1.78B
Constru in process -----15.03%279.68M-------------49.46%329.13M-----42.62%315.37M----16.93%651.23M
Productive biological assets ----------0------------------------0.00%713.39K
Oil and gas assets ----------0----------------------------
Intangible assets -15.42%492.61M-12.76%516.58M-14.41%531.29M-11.51%552.39M16.81%582.44M19.42%592.17M31.11%620.72M30.49%624.21M46.84%498.63M45.61%495.87M
Development expenditure ------------------------------00.00%9.58M0.00%9.58M
Goodwill -0.01%146.67M-0.01%146.67M-0.01%146.67M-0.01%146.67M-71.55%146.69M-75.19%146.69M-76.35%146.69M-76.35%146.69M-26.71%515.65M-16.24%591.18M
Long deferred expense -41.64%41.44M-41.56%45.98M-43.89%50.03M-32.32%60.87M-38.75%71.01M-28.73%78.68M-32.62%89.16M-28.06%89.93M-13.28%115.94M-18.09%110.4M
Deferred tax assets 190.26%287.25M249.89%283.71M137.80%243.38M166.64%284.44M-16.61%98.97M-32.77%81.08M-13.63%102.35M-13.17%106.68M-0.37%118.68M5.06%120.6M
Usufruct assets 91.78%5.28M59.33%5.73M37.02%6.54M-60.95%2.52M-91.23%2.75M-92.09%3.6M-89.68%4.77M-88.28%6.45M-41.92%31.36M-24.28%45.52M
Other non current assets -45.55%345.07M-46.16%357.43M-54.61%385.44M-61.97%391.13M76.29%633.79M84.82%663.93M111.00%849.17M163.13%1.03B276.74%359.52M264.05%359.23M
Total non current assets -8.16%4.85B-3.63%4.92B-3.20%5.07B-6.21%5.17B-3.90%5.28B-10.31%5.1B-8.70%5.24B-3.71%5.51B-4.29%5.5B0.44%5.69B
Total assets -5.79%16.42B-13.98%15.73B-18.92%15.56B-8.85%16.71B-26.74%17.43B-29.10%18.28B-30.28%19.19B-30.55%18.33B-17.58%23.79B-12.54%25.78B
Liabilities
Current liabilities
Short term loan 76.16%6.51B30.48%5.53B-12.40%4.8B70.74%6.56B-32.50%3.7B-25.32%4.24B11.69%5.48B-7.81%3.84B-20.93%5.48B-28.10%5.68B
Notes payable and accounts payable -53.88%3.26B-49.55%3.68B-39.30%4.23B-51.75%3.72B-8.84%7.06B-11.87%7.29B-28.35%6.98B-21.21%7.71B1.48%7.74B16.07%8.27B
-Notes payable -84.88%733.84M-79.35%1.02B-67.37%1.51B-91.30%448.6M6.68%4.85B-2.63%4.93B-25.66%4.62B-19.86%5.16B13.40%4.55B57.38%5.06B
-Accounts payable 14.26%2.52B12.64%2.66B15.68%2.73B28.02%3.27B-30.93%2.21B-26.43%2.36B-33.09%2.36B-23.78%2.56B-11.72%3.2B-17.91%3.21B
Contract liabilities -11.71%24.95M-13.81%27.31M-57.76%17.54M-8.45%29.12M-74.09%28.26M-72.97%31.68M-64.73%41.53M-81.80%31.8M-32.61%109.07M-27.20%117.21M
Advance receipts ----------0------------------627.17K--------
Salaries payable 9.04%18.69M-1.08%18.1M-17.47%17.87M-20.92%17.91M-49.18%17.14M-53.01%18.3M-40.15%21.65M-59.41%22.65M-17.10%33.73M-6.19%38.94M
Taxs payable 44.35%24.74M13.71%19.77M-64.05%16.17M-48.55%14.78M-84.45%17.14M-86.76%17.39M-76.10%44.99M-84.97%28.73M-42.38%110.21M-32.90%131.39M
Other payable (including interest and dividends) -54.88%273.4M-56.47%278.42M-46.71%368.69M-56.68%316.91M-57.26%606M-58.31%639.65M-57.20%691.81M-58.55%731.62M-35.85%1.42B-34.38%1.53B
-Interest payable ------------------------------0--------
-Dividend payable -82.15%3.94M-89.37%3.94M-94.12%3.94M-94.12%3.94M-93.97%22.09M-90.64%37.09M-87.12%67.09M-87.12%67.09M260.96%366.6M514.09%396.34M
-Other payable -----54.45%274.47M-------------47.05%602.56M-----46.60%664.53M-----49.95%1.14B
Non current liabilities due within one year -71.89%2.95M-72.45%3.05M694.15%8.99M-26.50%6.12M190.81%10.51M132.55%11.08M-81.75%1.13M-49.17%8.33M-42.66%3.61M-26.70%4.76M
Other current liabilities -47.12%42.08M10.19%99.71M60.97%115.73M8.32%97.59M-56.67%79.57M-61.52%90.49M-93.30%71.89M-69.72%90.09M-85.77%183.65M-82.45%235.16M
Total current liabilities -11.80%10.16B-21.73%9.65B-28.13%9.58B-13.69%10.76B-23.66%11.52B-22.96%12.33B-24.79%13.33B-24.47%12.47B-18.59%15.09B-16.62%16.01B
Current liabilities
Long term loan 184.89%502.26M177.94%326.85M982.33%269.5M288.80%261.27M129.86%176.3M64.48%117.6M-65.89%24.9M38.56%67.2M53.40%76.7M--71.5M
Deferred tax liabilities 26.05%45.1M25.29%46.16M19.18%45.79M17.01%47.48M26.77%35.78M24.84%36.84M-54.02%38.42M-51.44%40.58M-81.05%28.23M-80.19%29.51M
Long term deferred income 177.25%4.84M-11.73%1.55M-15.09%1.59M-16.28%1.62M-26.99%1.75M-89.91%1.76M-89.31%1.87M-88.95%1.93M-88.03%2.39M-13.22%17.41M
Lease liabilities 302.48%4.27M264.66%4.54M53.37%4.64M-69.39%835.71K-95.93%1.06M-96.50%1.25M-92.04%3.03M-93.03%2.73M-50.63%26.09M-40.75%35.62M
Other non current liabilities ----------------------------------12.71M--7.41M
Total non current liabilities 158.96%556.48M140.79%379.11M371.32%321.52M176.77%311.21M47.07%214.89M-2.48%157.45M-68.90%68.22M-42.64%112.44M-46.24%146.12M-30.18%161.46M
Total liabilities -8.68%10.71B-19.68%10.03B-26.09%9.9B-11.99%11.07B-22.98%11.73B-22.75%12.49B-25.33%13.4B-24.68%12.58B-18.99%15.23B-16.79%16.17B
Shareholders equity
Paid-in capital 0.00%1.5B0.00%1.5B0.00%1.5B0.00%1.5B0.00%1.5B0.00%1.5B0.00%1.5B0.00%1.5B0.00%1.5B0.00%1.5B
Capital reserve funds 1.69%3.59B1.86%3.59B0.30%3.72B0.52%3.72B4.82%3.53B-7.95%3.52B-2.42%3.71B-7.83%3.7B-16.31%3.36B-4.85%3.82B
Surplus reserve funds 4.42%159.53M4.42%159.53M4.42%159.53M4.42%159.53M0.00%152.77M0.00%152.77M0.00%152.77M0.00%152.77M13.41%152.77M13.41%152.77M
Retained profit 4.67%313.54M-1.69%305.76M2.64%309.47M5.15%294.3M-86.21%299.57M-85.76%311.01M-86.09%301.51M-86.83%279.89M1.55%2.17B2.55%2.18B
Less:Treasury stock --57.65M--57.65M0.00%230.65M0.00%230.65M--------0.00%230.65M0.00%230.65M0.00%230.65M0.00%230.65M
Shareholders equity without minority interests 0.41%5.51B0.17%5.5B0.48%5.46B0.75%5.45B-21.26%5.48B-26.18%5.49B-26.48%5.44B-28.54%5.41B-7.98%6.96B-1.62%7.44B
Minority interests -6.33%199.14M-35.33%195.23M-45.42%192.59M-45.00%189.18M-86.66%212.6M-86.14%301.9M-83.83%352.84M-83.82%344M-36.13%1.59B-12.52%2.18B
Total shareholder equity 0.16%5.71B-1.68%5.69B-2.32%5.66B-1.99%5.64B-33.44%5.7B-39.77%5.79B-39.55%5.79B-40.67%5.75B-14.96%8.56B-4.32%9.61B
Total liabilityies and equity -5.79%16.42B-13.98%15.73B-18.92%15.56B-8.85%16.71B-26.74%17.43B-29.10%18.28B-30.28%19.19B-30.55%18.33B-17.58%23.79B-12.54%25.78B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership)------Tianyuanquan Certified Public Accountants Firm (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.